Executive Summary The Craniopharyngioma Treatment Market is a specialized segment of the neuro-oncology industry dedicated to the management of rare, histologically benign but clinically aggressive tumors located near the pituitary gland and hypothalamus. As of 2026, the market is valued at approximately USD 1.96 Billion and is characterized by a significant shift toward...